Heart Beat: 03/07

Patients fitted with drug-coated stents are advised to stay on anti-clotting drugs for at least a year. The advisory recommends doctors tell their patients to take an anti-clotting drug such as clopidogrel and aspirin for a year to reduce the risk of clotting, which could lead to a heart attack or death. The long-term safety of clopidogrel bisulfate (Plavix) in stent patients has not been established.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access